Ennature Bio Pharma reported a profit after tax of Rs 4.89 crore for the September quarter of FY27. This marks a strong turnaround from the loss of Rs 1.28 crore seen last year. Revenue grew to Rs 78.46 crore, as the company shared its first results after the recent demerger.
Ennature Bio Pharma has achieved a profit after tax of Rs 4.89 crore in the second quarter of FY27, a notable turnaround from a loss of Rs 1.28 crore last year. The quarterly revenue surged to Rs 78.46 crore, compared to Rs 54.14 crore the previous year. Furthermore, the company reported an EBITDA of Rs 10.34 crore, marking its first results post-demerger from India Glycols Ltd.
Ennature Bio Pharma on Saturday reported a profit after tax (PTI) of Rs 4.89 crore for September quarter FY27.
The company had incurred a loss of Rs 1.28 crore a year ago.
Revenue grew to Rs 78.46 crore during the quarter under review from Rs 54.14 crore a year ago, the company said in a statement.
The company's earnings before interest, taxes, depreciation, and amortisation (EBITDA) during the second quarter increased to Rs 10.34 crore from Rs 6.04 crore in Q2 FY26.
These are the company's first quarterly results following the demerger from India Glycols Ltd, the statement added.